Anastrozole Shows Long-Lasting Breast Cancer Prevention Power

THURSDAY, Dec. 12, 2019 -- Nearly six years after stopping a five-year regimen of the breast cancer drug anastrozole, women at high risk for breast cancer were 50% less likely to have been struck by the disease, new research shows. The trial...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news